Liquid Chromatography-Mass Spectrometry Metabolomic Analysis of Terminalia ferdinandiana Exell. Fruit Extracts That Inhibit HIV-1 Cell Infection, HIV-1 Reverse Transcriptase and HIV-1 Protease
Molecules · 2025
DOI: 10.3390/molecules30081701 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Ian Edwin Cock und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Planetary Health and Food Security, Griffith University, Brisbane 4222, Australia. Hauptthemen laut MEDLINE: Plant Extracts, HIV-1, Fruit, HIV Reverse Transcriptase. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Plum Landholdings, Australia.
Abstract (Originalsprache)
The emergence of HIV strains resistant to the current anti-retroviral drugs has necessitated the search for new anti-retroviral medications. Methanolic and aqueous T. ferdinandiana fruit extracts have potent inhibitory activity against several phases of the HIV-1 replicative cycle. Cell infectivity studies using a non-resistant HIV-1 pseudovirus demonstrated that the methanolic (IC50 16 µg/mL) and aqueous extracts (IC50 19 µg/mL) were potent inhibitors of viral infection in a non-replicating HIV-1 assay. Both extracts also inhibited HIV-1 reverse transcriptase (IC50 values of 35 and 33 µg/mL for methanolic and aqueous extracts, respectively) and HIV-1 protease (IC50 values of 19 and 27 µg/mL, respectively) in recombinant enzyme assays. Given their inhibitory activities against multiple phases of HIV-1 replication, T. ferdinandiana fruit extracts may be particularly useful as HIV-1 therapeutics. Furthermore, both extracts displayed good safety profiles and therapeutic indices, indicating their suitability for therapeutic usage. LC-MS metabolomic profiling analysis of the methanolic extract identified several interesting constituents, including a relative abundance of tannins, as well as several flavonoids and stilbenes. All of these compounds have previously been reported to have bioactivities consistent with the anti-HIV-1 activities reported herein. Based on these studies, methanolic and aqueous T. ferdinandiana fruit extracts are promising potential therapies for the prevention, treatment and management of HIV-1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Planetary Health and Food Security, Griffith University, Brisbane 4222, Australia.
- Queensland Brain Institute, University of Queensland, Brisbane 4072, Australia.
- Department of Molecular Medicine and Haematology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Parktown, Johannesburg 2193, South Africa.
ORCID-Profile: Ian Edwin Cock, Adriaan Erasmus Basson
Förderung
- Plum Landholdings, Australia
Zitieren
APA
Cock, I. E., Matthews, B., & Basson, A. E. (2025). Liquid Chromatography-Mass Spectrometry Metabolomic Analysis of Terminalia ferdinandiana Exell. Fruit Extracts That Inhibit HIV-1 Cell Infection, HIV-1 Reverse Transcriptase and HIV-1 Protease. Molecules. https://doi.org/10.3390/molecules30081701
Vancouver
Cock IE, Matthews B, Basson AE. Liquid Chromatography-Mass Spectrometry Metabolomic Analysis of Terminalia ferdinandiana Exell. Fruit Extracts That Inhibit HIV-1 Cell Infection, HIV-1 Reverse Transcriptase and HIV-1 Protease. Molecules. 2025. doi:10.3390/molecules30081701
BibTeX
@article{Cock2025,
author = {Cock, Ian Edwin and Matthews, Benjamin and Basson, Adriaan Erasmus},
title = {Liquid Chromatography-Mass Spectrometry Metabolomic Analysis of Terminalia ferdinandiana Exell. Fruit Extracts That Inhibit HIV-1 Cell Infection, HIV-1 Reverse Transcriptase and HIV-1 Protease},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30081701}
}
EUVIMED